Downregulation of lipopolysaccharide-induced intercellular adhesion molecule-1 expression via EP2/EP4 receptors by prostaglandin E2 in human fibroblasts

被引:19
作者
Noguchi, K
Iwasaki, K
Shitashige, M
Umeda, M
Izumi, Y
Murota, S
Ishikawa, I
机构
[1] Tokyo Med & Dent Univ, Grad Sch, Dept Hard Tissue Engn, Bunkyo Ku, Tokyo 1138549, Japan
[2] Tokyo Med & Dent Univ, Grad Sch, Sect Cellular Physiol Chem, Bunkyo Ku, Tokyo 1138549, Japan
[3] Kagoshima Univ, Sch Dent, Dept Periodontol, Kagoshima 8908544, Japan
关键词
prostaglandin E-2; lipopolysaccharide; ICAM-1; gingival fibroblasts;
D O I
10.1023/A:1007110304044
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In the present study, the effect of prostaglandin E-2 (PGE(2)) on intercellular adhesion molecule-1 (ICAM-1) expression in human gingival fibroblasts (HGF) stimulated with lipopolysaccharides (LPS) was investigated. LPS were isolated from periodontopathic bacteria, Actinobacillus actinomycetemcomitans (A. actinomytcetemcomitans) and Porphyromonas gingivalis (P. gingivalis), by the phenol-water method and Escherichia coli (E. call) LPS was used as a control. PGE(2) significantly inhibited A. actinoinmycetemcomitans-, P. gingivalis- and E. coli-LPS-induced ICAM-I expression. Next, of four PGE(2) receptor subtypes (EP1, EP2, EP3 and EP4), we examined which subtype(s) was involved in inhibition of LPS-elicited ICAM-I expression by PGE2. Eleven-deoxy-PGE(1), a selective EP2/EP4 agonist, and butaprost, a selective EP2 agonist, attenuated A. actinomycetemcomitans-, P. gingivalis- and E. coli-LPS-elicited ICAM-1 expression, although butaprost was less potent than PGE2 and 11-deoxy-PGE(1). Sulprostone, an EP1/EP3 agonist, and ONO-AP-324, an EP3 agonist, was inert to the LPS-elicited ICAM-1 expression. Furthermore, dibutyryl cAMP, a cAMP analogue, and forskolin, an adenylate cyclase activator, downregulated A. actinomycetemcomitans- P. gingivalis- and E. coli-LPS-elicited ICAM-I expression in HGF Our data suggest that PGE2 downregulates A. actinomycetemcomitans- and P. gingivalis-LPS-induced ICAM-I expression in HGF, via EP2/EP4 receptors by cAMP-dependent signaling pathways. The cAMP-elevating agents such as EP2/EP4 receptor activators may serve to control inflammatory and immune responses in periodontal disease.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 45 条
[1]  
AHLUWALIA A, 1994, J PHARMACOL EXP THER, V268, P1526
[2]   ISOFORMS OF THE EP3 SUBTYPE OF HUMAN PROSTAGLANDIN E(2) RECEPTOR TRANSDUCE BOTH INTRACELLULAR CALCIUM AND CAMP SIGNALS [J].
AN, SZ ;
YANG, JH ;
SO, SW ;
ZENG, L ;
GOETZL, EJ .
BIOCHEMISTRY, 1994, 33 (48) :14496-14502
[3]   CLONING AND EXPRESSION OF THE EP2 SUBTYPE OF HUMAN RECEPTORS FOR PROSTAGLANDIN-E2 [J].
AN, SZ ;
YANG, JH ;
XIA, MH ;
GOETZL, EJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (01) :263-270
[4]   Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope [J].
Bhattacharya, M ;
Peri, K ;
Ribeiro-da-Silva, A ;
Almazan, G ;
Shichi, H ;
Hou, X ;
Varma, DR ;
Chemtob, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (22) :15719-15724
[5]  
COLEMAN RA, 1995, ADV PROSTAG THROMB L, V23, P283
[6]  
COLEMAN RA, 1994, PHARMACOL REV, V46, P205
[7]   TRANSCRIPTIONAL REGULATION OF ENDOTHELIAL-CELL ADHESION MOLECULES - NF-KAPPA-B AND CYTOKINE-INDUCIBLE ENHANCERS [J].
COLLINS, T ;
READ, MA ;
NEISH, AS ;
WHITLEY, MZ ;
THANOS, D ;
MANIATIS, T .
FASEB JOURNAL, 1995, 9 (10) :899-909
[8]   LEVELS OF PROSTAGLANDIN-E2, THROMBOXANE, AND PROSTACYCLIN IN PERIODONTAL TISSUES [J].
DEWHIRST, FE ;
MOSS, DE ;
OFFENBACHER, S ;
GOODSON, JM .
JOURNAL OF PERIODONTAL RESEARCH, 1983, 18 (02) :156-163
[9]   PROSTAGLANDIN ENDOPEROXIDE SYNTHASE - REGULATION OF ENZYME EXPRESSION [J].
DEWITT, DL .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1083 (02) :121-134
[10]   BINDING OF THE INTEGRIN MAC-1 (CD11B/CD18) TO THE 3RD IMMUNOGLOBULIN-LIKE DOMAIN OF ICAM-1 (CD54) AND ITS REGULATION BY GLYCOSYLATION [J].
DIAMOND, MS ;
STAUNTON, DE ;
MARLIN, SD ;
SPRINGER, TA .
CELL, 1991, 65 (06) :961-971